Jump to content

1,3-Benzodioxolyl-N-methylpentanamine

From Wikipedia, the free encyclopedia
(Redirected from UWA-091)
1,3-Benzodioxolyl-N-methylpentanamine
Names
Preferred IUPAC name
1-(2H-1,3-Benzodioxol-5-yl)-N-methylpentan-2-amine
Other names
3,4-Methylenedioxy-α-propyl-N-methyl-2-phenethylamine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C13H19NO2/c1-3-4-11(14-2)7-10-5-6-12-13(8-10)16-9-15-12/h5-6,8,11,14H,3-4,7,9H2,1-2H3
    Key: PZVRSDBLMSXDCX-UHFFFAOYSA-N
  • C1=C2C(=CC=C1CC(NC)CCC)OCO2
Properties
C13H19NO2
Molar mass 221.30 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

N-Methyl-1,3-benzodioxolylpentanamine (MBDP; Methyl-K, UWA-091), also known as 3,4-methylenedioxy-α-propyl-N-methylphenethylamine, is a psychoactive drug of the phenethylamine chemical class. It is the N-methyl analogue of 1,3-benzodioxolylpentanamine (BDP; K). Methyl-K was first synthesized by Alexander Shulgin ("Sasha" Shulgin). In his book PiHKAL ("Phenethylamines i Have Known And Loved"), the minimum dosage is listed as 100 mg, and the duration is unknown.[1] Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of Methyl-K.

Legality

[edit]

United Kingdom

[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]

See also

[edit]

References

[edit]
  1. ^ Methyl-K entry in PiHKAL
  2. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.